Lunsky, Y, Klein-Geltink, JE, Yates, EA, (eds). Atlas on the Primary Care of Adults with Developmental Disabilities in Ontario.
Institute for Clinical Evaluative Sciences & Centre for Addiction and Mental Health, 2013.
Sheehan, R, Hassiotis, A, Walters, K, Osborn, D, Strydom, A, Horsfall, L. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ
2015; 351: h4326.
Cooper, S-A, Smiley, E, Morrison, J, Williamson, A, Allan, L. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry
2007; 190: 27–35.
Morgan, VA, Leonard, H, Bourke, J, Jablensky, A. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. Br J Psychiatry
2008; 193: 364–72.
Brylewski, J, Duggan, L. Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database Syst Rev
2004; 3: CD000377.
Glover, G, Bernard, S, Branford, D, Holland, A, Strydom, A. Use of medication for challenging behaviour in people with intellectual disability. Br J Psychiatry
2014; 205: 6–7.
Teeluckdharry, S, Sharma, S, O'Rourke, E, Tharian, P, Gondalekar, A, Nainar, F, et al. Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability. J Intellect Disabil
2013; 17: 223–35.
Frighi, V, Stephenson, MT, Morovat, A, Jolley, IE, Trivella, M, Dudley, CA, et al. Safety of antipsychotics in people with intellectual disability. Br J Psychiatry
2011; 199: 289–95.
Newcomer, JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry
2007; 68(Suppl 1): 20–7.
Nasrallah, HA. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. J Clin Psychiatry
2007; 68(Suppl 1): 5–11.
Azimi, K, Raina, P, Lunsky, Y. Brief report: occurrence of metabolic syndrome in patients with intellectual disability treated with atypical antipsychotics. J Dev Disabil
2011; 17: 47–50.
Gazizova, D, Puri, BK, Singh, I, Dhaliwal, R. The overweight: obesity and plasma lipids in adults with intellectual disability and mental illness. J Intellect Disabil Res
2012; 56: 895–901.
Lin, E, Balogh, R, Cobigo, V, Ouellette-Kuntz, H, Wilton, AS, Lunsky, Y. Using administrative health data to identify individuals with intellectual and developmental disabilities: a comparison of algorithms. J Intellect Disabil Res
2013; 57: 462–77.
Levy, AR, O'Brien, BJ, Sellors, C, Grootendorst, P, Willison, D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol
2003; 10: 67–71.
Juurlink, D, Preyra, C, Croxford, R, Chong, A, Austin, P, Tu, J, et al. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study.
Canadian Institute for Health Information, 2006.
Hirdes, JP, Smith, TF, Rabinowitz, T, Yamauchi, K, Perez, E, Telegdi, NC, et al. The Resident Assessment Instrument-Mental Health (RAI-MH): inter-rater reliability and convergent validity. J Behav Health Serv Res
2002; 29: 419–32.
Urbanoski, KA, Mulsant, BH, Willett, P, Ehtesham, S, Rush, B. Real-world evaluation of the Resident Assessment Instrument-Mental Health assessment system. Can J Psychiatry
2012; 57: 687–95.
American Association on Intellectual & Developmental Disabilities. Intellectual Disability: Definition, Classification, and Systems of Supports, 11th ed.
American Association on Intellectual & Developmental Disabilities, 2011.
Quan, H, Khan, N, Hemmelgarn, BR, Tu, K, Chen, G, Campbell, N, et al. Validation of a case definition to define hypertension using administrative data. Hypertension
2009; 54: 1423–8.
Hux, JE, Ivis, F, Flintoft, V, Bica, A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care
2002; 25: 512–6.
Tagalakis, V, Kahn, SR. Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf
2011; 20: 304–7.
The Johns Hopkins ACG System. Technical Reference Guide Version 9.0.
Health Services Research & Development Center, Johns CHopkins University, Bloomberg USchool of Public Health, 2009.
Normand, ST, Landrum, MB, Guadagnoli, E, Ayanian, JZ, Ryan, TJ, Cleary, PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol
2001; 54: 387–98.
Berry, SD, Ngo, L, Samelson, EJ, Kiel, DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc
2010; 58: 783–7.
Fine, JP, Gray, RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc
1999; 94: 496–509.
SAS Software. Version 9.3 of the SAS System for Unix. SAS Institute Incorporated, 2012.
Tsakanikos, E, Bouras, N, Sturmey, P, Holt, G. Psychiatric co-morbidity and gender differences in intellectual disability. J Intellect Disabil Res
2006; 50: 582–7.
Balogh, RS, Lake, JK, Lin, E, Wilton, A, Lunsky, Y. Disparities in diabetes prevalence and preventable hospitalizations in people with intellectual and developmental disability: a population-based study. Diabet Med
2015; 32: 235–42.
Lunsky, Y, Bradley, EA, Gracey, CD, Durbin, J, Koegl, C. Gender differences in psychiatric diagnoses among inpatients with and without intellectual disabilities. Am J Intellect Dev Disabil
2009; 114: 52–60.
Matson, JL, Neal, D. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview. Res Dev Disabil
2009; 30: 572–86.
Leucht, S, Bradley, EA, Gracey, CD, Durbin, J, Koegl, C. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet
2009; 373: 31–41.
Merriman, S, Haw, C, Kirk, J, Stubbs, J. Risk factors for coronary heart disease among inpatients who have mild intellectual disability and mental illness. J Intellect Disabil Res
2005; 49: 309–16.
Valdovinos, M, Parsa, R, Alexander, M. Results of a Nation-Wide survey evaluating psychotropic medication use in Fragile X Syndrome. J Dev Phys Disabil
2009; 21: 23–37.
Bhaumik, S, Watson, JM, Thorp, CF, Tyrer, F, McGrother, CW. Body mass index in adults with intellectual disability: distribution, associations and service implications: a population-based prevalence study. J Intellect Disabil Res
2008; 52: 287–98.
Tenenbaum, A, Chavkin, M, Wexler, ID, Korem, M, Merrick, J. Morbidity and hospitalizations of adults with Down syndrome. Res Dev Disabil
2012; 33: 435–41.
Humphries, K, Traci, MA, Seekins, T. Nutrition and adults with intellectual or developmental disabilities: systematic literature review results. Intellect Dev Disabil
2009; 47: 163–85.
de Winter, CF, Bastiaanse, LP, Hilgenkamp, TI, Evenhuis, HM, Echteld, MA. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HAID study. Res Dev Disabil
2012; 33: 1722–31.
Hagg, S, Spigset, O. Antipsychotic-induced venous thromboembolism: a review of the evidence. CNS Drugs
2002; 16: 765–76.
Moores, L, Bilello, KL, Murin, S. Sex and gender issues and venous thromboembolism. Clin Chest Med
2004; 25: 281–97.
Aichhorn, W, Whitworth, AB, Weiss, EM, Marksteiner, J. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?
2006; 29: 587–98.
de Kuijper, G, Mulder, H, Evenhuis, H, Scholte, F, Visser, F, Hoekstra, PJ. Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Res Dev Disabil
2013; 34: 2799–809.
Tyrer, P, Cooper, SA, Hassiotis, A. Drug treatments in people with intellectual disability and challenging behaviour. BMJ
2014; 349: g4323.
Baburaj, R, El Tahir, M. Monitoring for Metabolic Syndrome in People with Intellectual Disability on Antipsychotic Medication.
Advances in Mental Health and Intellectual Disabilities, 2011.